6 completed, 1 unknown. 7 Phase 1.
By phase and status
Follow Eva Pharma: new trials by email
Trials (filtered) newest first · largest first
All 7 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
An Open-label, Randomized, Single Oral Dose, Two-period, Two-sequence, Two-way, Crossover Bioequivalence Study on Healthy Adult Male Participants Under Fed Conditions to Compare, Test Product Palbociclib-EVAPHARMA 125 mg Hard Gelatin Capsule, Versus the Reference Product Ibrance™125 mg Capsules
Palbociclib-EVAPHARMA 125 mg Hard Gelatin Capsule, Ibrance capsules - Bioequivalence, Male | Phase 1 | Completed | 30 | 2026-02-09 | 2026-11-06 |
Bioequivalence Study of of Metformin HCl From Gleptomet 50/1000 mg F.C.Tablets (EVA Pharma, Egypt) and Janumet 50/1000 mg F.C.Tablets (Merck Sharp & Dohme, The Netherlands)
Gleptomet 50/1000(Metformin HCl & Sitagliptin), Janumet 50/1000(Metformin HCl & Sitagliptin) - Healthy | Phase 1 | Completed | 30 | 2022-11-29 | 2023-04-05 |
Bioequivalence Study of Nirmatrelvir & Ritonavir From Copaxid 150 +100 mg Tablets (Eva Pharma, Egypt) Versus Paxlovid 150 + 100 mg Film Coated Tablets (Pfizer Europe, Belgium)
Nirmatrelvir 150 mg + Ritonavir 100 mg (Reference first dose), Nirmatrelvir 150 mg + Ritonavir 100 mg (test), Nirmatrelvir 150 mg + Ritonavir 100 mg (Reference second dose) - Healthy | Phase 1 | Completed | 28 | 2022-08-21 | 2023-01-18 |
Safety and Immunogenicity Study of EgyVax Vaccine Candidate for Prophylaxis of COVID-19 Infection
EgyVax Vaccine Candidate, Placebo - COVID-19 | Phase 1 | Unknown | 45 | 2022-02-06 | 2022-02-23 |
Bioequivalence Study of Ivermectin From Revemact 6 mg Tablets (Man. by EVA Pharma for Horus for Pharmaceutical Industries, Egypt) and Stromectol 2*3 mg Tablets (Merck Sharp & Dohme B.V., Haarlem, The Netherlands)
Revemact, Stromectol (first dose), Stromectol (second dose) - Healthy | Phase 1 | Completed | 30 | 2021-01-28 | 2021-04-27 |
Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)
Prevaglip (linagliptin), Trajenta (linagliptin) - Healthy | Phase 1 | Completed | 24 | 2016-02-01 | 2016-08-05 |
Bioequivalence Study of Vildagliptin From Gliptus 50 mg Tablet (EVA Pharma, Egypt) and Galvus 50 mg Tablet (NOVARTIS PHARMA, GERMANY)
Vildagliptin - Healthy | Phase 1 | Completed | 24 | 2014-02-01 | 2016-06-29 |
Conditions studied
COVID-19 (1)
Interventions
Ivermectin (1) · Linagliptin (1) · Ritonavir (1) · Sitagliptin Phosphate (1) · Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination (1) · Vildagliptin (1) · nirmatrelvir (1) · nirmatrelvir and ritonavir drug combination (1) · palbociclib (1)
Countries
Egypt (7)
Top investigators
Ahmed Elshafeey, Ph.D. Pharma (5) · Eman Nouman (1) · Mohammed Abdulhafez (1)